Oxford Biodynamics

Oxford BioDynamics (OBD) is a health-care service company with a proprietary biomarker discovery platform, EpiSwitch, based on the latest advances in the mechanisms of gene expression, non-coding RNA and epigenetics. The technology allows: 1. Screening; early detection and monitoring of major diseases associated with aberrant gene expression, i.e. Cancer, neurodegenerative conditions, such as Alzheimer’s disease, and inflammatory conditions. 2. Early detection of aberrant expression in a very low copy number of abnormal cells, literally “finding a needle in a hay stack” at the early stage of the disease EpiSwitch способна определять 2 типа маркеров: Disease-related biomarkers (diagnostic biomarker and prognostic biomarker) и Drug-related biomarkers.

Main

03/08/2007
04/01/2007
01/01/2008
02/01/2009
03/01/2009
02/01/2010

Fundraising

04/01/2009
11/01/2011

Publications

02/07/2007
07/15/2010
10/01/2010
11/01/2011
01/01/2014

Patents

02/17/2006
08/23/2007
11/25/2009
07/29/2011
08/10/2011
10/01/2011
04/10/2012
08/01/2012
09/01/2012
02/05/2013
08/23/2013
10/30/2013
02/01/2014

Validation

08/01/2009
07/01/2010
08/01/2010
09/01/2010
10/01/2010
06/01/2011
10/01/2011
01/01/2012
03/01/2012
03/02/2012
03/03/2012
07/01/2012
11/10/2012
11/01/2013

Collaboration

09/01/2007
05/01/2008
09/01/2008
10/01/2008
10/01/2008
12/01/2008
03/01/2009
04/01/2009
07/01/2009
09/01/2009
06/01/2010
11/01/2010
04/01/2011
12/01/2011
12/01/2011
05/02/2012
06/01/2012
10/01/2012
03/01/2013
03/02/2013
05/02/2013
05/10/2013
06/01/2013
06/02/2013
12/01/2013
01/01/2014
01/02/2014
01/10/2014
01/11/2014

Appointments

06/01/2007
06/02/2007
01/01/2008
06/01/2008
01/01/2010
04/01/2012

Events

02/09/2009
09/24/2012
08/27/2013
10/02/2013

Product Development

06/02/2007
01/01/2009
02/01/2009
12/01/2009
04/01/2010
05/01/2010
03/04/2012
04/01/2013